Buckingham Capital Management, Inc. Abbott Laboratories Transaction History
Buckingham Capital Management, Inc.
- $863 Million
- Q3 2024
A detailed history of Buckingham Capital Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 45,409 shares of ABT stock, worth $5.23 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
45,409
Previous 75,224
39.63%
Holding current value
$5.23 Million
Previous $7.82 Million
33.76%
% of portfolio
0.6%
Previous 0.95%
Shares
24 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.4 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.84 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.58 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.14 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $202B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...